FOXO1 and non-small cell lung carcinoma: Expression of p-PI3K, p-AKT, c-JUN and CCND1 was enhanced, while expression of p27 and p21 were decreased in FOXO1-overexpressing NSCLC cells with miR-3188 inhibitor treatment, (Figure 5).